These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22327500)

  • 1. Plant-derived vaccines: an approach for affordable vaccines against cervical cancer.
    Waheed MT; Gottschamel J; Hassan SW; Lössl AG
    Hum Vaccin Immunother; 2012 Mar; 8(3):403-6. PubMed ID: 22327500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential of plants for the production and delivery of human papillomavirus vaccines.
    Rosales-Mendoza S; Govea-Alonso DO
    Expert Rev Vaccines; 2015 Jul; 14(7):1031-41. PubMed ID: 25882610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advantages and disadvantages of current prophylactic vaccines against HPV.
    Madrid-Marina V; Torres-Poveda K; López-Toledo G; García-Carrancá A
    Arch Med Res; 2009 Aug; 40(6):471-7. PubMed ID: 19853187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus vaccines in plants.
    Giorgi C; Franconi R; Rybicki EP
    Expert Rev Vaccines; 2010 Aug; 9(8):913-24. PubMed ID: 20673013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus vaccines: new tools for accelerating cervical cancer prevention in developing countries.
    Luciani S; Jauregui B; Kieny C; Andrus JK
    Immunotherapy; 2009 Sep; 1(5):795-807. PubMed ID: 20636024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New advances in vaccine technology and improved cervical cancer prevention.
    Huh WK; Kendrick JE; Alvarez RD
    Obstet Gynecol; 2007 May; 109(5):1187-92. PubMed ID: 17470604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospects and prejudices of human papillomavirus vaccines in India.
    Das BC; Hussain S; Nasare V; Bharadwaj M
    Vaccine; 2008 May; 26(22):2669-79. PubMed ID: 18455843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventive and therapeutic HPV vaccines.
    Monie A; Hung CF; Wu TC
    Curr Opin Investig Drugs; 2007 Dec; 8(12):1038-50. PubMed ID: 18058574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV & HPV vaccination: issues in developing countries.
    Bharadwaj M; Hussain S; Nasare V; Das BC
    Indian J Med Res; 2009 Sep; 130(3):327-33. PubMed ID: 19901442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chapter 17: Second generation HPV vaccines to prevent cervical cancer.
    Schiller JT; Nardelli-Haefliger D
    Vaccine; 2006 Aug; 24 Suppl 3():S3/147-53. PubMed ID: 16950002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of human papillomavirus (HPV) infection and cervical cancer in China: how does HPV vaccination bring about benefits to Chinese women?
    Liu X; Feng A; Cui Y; Tobe RG
    Biosci Trends; 2013 Aug; 7(4):159-67. PubMed ID: 24056165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccines against human papillomavirus: perspectives for controlling cervical cancer.
    García Carrancá A; Galván SC
    Expert Rev Vaccines; 2007 Aug; 6(4):497-510. PubMed ID: 17669005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus, cervical cancer, and the vaccines.
    Tovar JM; Bazaldua OV; Vargas L; Reile E
    Postgrad Med; 2008 Jul; 120(2):79-84. PubMed ID: 18654072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine.
    Monsonego J; Cortes J; Greppe C; Hampl M; Joura E; Singer A
    Vaccine; 2010 Nov; 28(51):8065-72. PubMed ID: 20971114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Human papillomavirus and carcinoma of the cervix vaccines against the human papillomavirus-promise of an efficacious prevention].
    Kohl I
    Klin Mikrobiol Infekc Lek; 2006 Jun; 12(3):91-7. PubMed ID: 17051469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus: science and technologies for the elimination of cervical cancer.
    Bosch FX
    Expert Opin Pharmacother; 2011 Oct; 12(14):2189-204. PubMed ID: 21756205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of human papillomavirus immunization in the developing world.
    Kane MA; Serrano B; de Sanjosé S; Wittet S
    Vaccine; 2012 Nov; 30 Suppl 5():F192-200. PubMed ID: 23199963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant vaccines for the prevention of human papillomavirus infection and cervical cancer.
    Palmer KE; Jenson AB; Kouokam JC; Lasnik AB; Ghim SJ
    Exp Mol Pathol; 2009 Jun; 86(3):224-33. PubMed ID: 19454268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vaccination against human papillomavirus. Implementation and efficacy against cervical cancer control].
    Bégué P; Henrion R; Blanc B; Girard M; Sancho-Garnier H
    Bull Acad Natl Med; 2007 Dec; 191(9):1805-16; discussion 1816-7. PubMed ID: 18663976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus vaccines: current issues & future.
    Kawana K; Yasugi T; Taketani Y
    Indian J Med Res; 2009 Sep; 130(3):341-7. PubMed ID: 19901444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.